Ion channels - New opportunities for an established therapeutic target class

Drug Discovery World

Volumn 6, Issue 3, 2005, Pages 17-23

  Southan, Andrew ^a   James, Iain F ^a   Cronk, David ^a  

^a Ion Channel Pharmacology at BioFocus ^*

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE BESYLATE; ANTICONVULSIVE AGENT; CARBAMAZEPINE; CHLORIDE CHANNEL; G PROTEIN COUPLED RECEPTOR; GLIMEPIRIDE; ION CHANNEL; NIFEDIPINE; SODIUM CHANNEL BLOCKING AGENT; VOLTAGE GATED SODIUM CHANNEL;

ARTICLE; DRUG BINDING; DRUG DESIGN; DRUG INDUSTRY; DRUG MANUFACTURE; DRUG MARKETING; DRUG POTENCY; DRUG TARGETING; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN GENOME; MOLECULAR BIOLOGY;

EID: 22544463134     PISSN: 14694344     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Hille, B (2001). Ion channels of excitable membranes. Sinauer Associates, Massachusetts.
2. Xu, J et al (2001). Ion-channel assay technologies: quo vadis? Drug Discovery Today 6(24):1278-1287.
3. Birch, P et al (2004). Strategies to identify ion channel modulators: current and novel approaches to target neuropathic pain. Drug Discovery Today 9(9): 410-418.
4. Denyer, J et al (1998). HTS approaches to voltage gated ion channel drug discovery. Drug Discovery Today 3(7):323-332.
5. Owen, D and Silverthorne, A (2002). Channeling drug discovery: current trends in ion channel drug discovery research. Drug Discovery World Spring:48-61.
6. Terstappen, G (1999). Functional analysis of native and recombinant ion channels using a high capacity nonradioactive rubidium efflux assay. Anal. Biochem. 272:149-155.
7. Scott, CW et al. (2003).A medium-throughput functional assay of KCNQ2 potassium channels using rubidium efflux and atomic absorption spectroscopy. Anal. Biochem. 319:251-257.
8. 2+-activated K+ channels: ion flux studies by atomic absorption spectroscopy. Assay Drug Dev. Tech. 1:647-654.
9. Trivedi, S (2005). A nonradioactive lithium influx assay using atomic absorption spectroscopy for identifying sodium channel modulators. Paper presented at Ion Channel Retreat, Vancouver BC.
10. Weaver, CD et al (2004).A thallium-sensitive, fluorescence-based assay for detecting and characterizing potassium channel modulators in mammalian cells. Journal of Biomolecular Screening 9:671-677.
11. Galietta, I, Jayaraman, S and Verkman, AS (2001). Cell-based assay for high-throughput quantitative screening of CFTR chloride transport channels. Am. J. Physiol: Cell Physiol. 281:C1734-C1742.
12. Tang, W and Wildey, MJ (2004). Development of a colorimetric method or functional chloride channel assay. Journal of Biomolecular Screening 9:607-613.
13. Cronk, D (2001). Cell based high throughput screening of ion channels using FLIPR and VIPR membrane potential assay technology. Paper presented at the annual meeting of the Society for Biomolecular Screening, Baltimore, MD.
14. Wolff, C, Fuks, B and Chatelain, P (2003). Comparative study of membrane potential-sensitive fluorescent probes and their use in ion channel screening assays. Journal of Biomolecular Screening 8:533-543.
15. Gonzalez, J and Tsien, R (1997). Improved indicators of cell membrane potential that use fluorescence resonance energy transfer. Chem Biol 4:269-277.
16. Falconer, M et al (2002). High-throughput screening for ion channel modulators. JBS 7:460-465.
17. Chang, SM et al (2004). Comparison of the pharmacological properties of rat NaV1.8 with rat NaV1.2a and human NaV1.5 voltage-gated sodium channel subtypes using a membrane potential sensitive dye and FLIPR. Receptors & Channels 10:11-23.
18. Maher, M and Gonzalez, J (2002). Ion channel assay methods International patent application WO02/08748.
19. Huang, T et al (2003). Identification of use-dependent blockers of voltage-gated sodium channels with a novel high-throughput optical assay. Annual meeting of the Society for Neuroscience, Washington, DC, Abstract 8.10.
20. Asmild, M et al (2003). Upscaling and automation of electrophysiology: Toward high throughput screening in ion channel drug discovery. Receptors & Channels 9: 49-58.